focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.00
Bid: 291.00
Ask: 300.00
Change: 3.50 (1.20%)
Spread: 9.00 (3.093%)
Open: 294.00
High: 295.00
Low: 294.00
Prev. Close: 292.00
BMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares / PDMR Shareholding

22 Dec 2022 07:00

RNS Number : 5939K
Braemar PLC
22 December 2022
 

 

22 December 2022

BRAEMAR PLC

("Braemar", the "Company" or the "Group")

Issue of Shares / PDMR Shareholding

 

Braemar, a leading international Shipbroker and provider of expert advice in shipping investment, chartering and risk management announces that application has been made for 37,636 new ordinary shares of 10p each in the capital of the Company ("Ordinary Shares") to be admitted to the Official List of the UK Listing Authority and to trading on London Stock Exchange's Main Market for listed securities ('Admission'). It is expected Admission will become effective and trading will commence at 8.00 a.m. on 5 January 2023.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company.

The new Ordinary Shares have been allotted as part of the agreed rescheduling of deferred consideration amounts owed by Braemar in relation to its acquisition of Braemar Corporate Finance (formerly known as "Braemar NAVES"), as previously announced on 3 June 2021. The new Ordinary Shares will be allotted in satisfaction of amounts due for repayment to persons closely associated with Axel Siepmann, a Managing Director of Braemar Corporate Finance and a PDMR of the Company, and Mark Kuchenbecker, a former Managing Director of Braemar Corporate Finance and former PDMR of the Company. The new Ordinary Shares were subscribed for at 315.7p per share, which was calculated using the volume weighted average price per Ordinary Share for the 30 consecutive trading days prior to subscription.

Following this share issue, the total holding of Ordinary Shares of Axel Siepmann (including those persons closely associated with him) is as follows:

Name

Title

Shares

% of Company's issued share capital

Axel Siepmann

Managing Director of Braemar Corporate Finance

164,4441

0.50%

1 Includes 86,308 Ordinary Shares held by an entity jointly owned by Axel Siepmann.

Connected parties of Axel Siepmann and the other sellers of Braemar Corporate Finance continue to hold convertible loan notes issued as consideration for the acquisition of Braemar Corporate Finance in 2017 amounting to approximately €4.4m. Further information on these loan notes and their redemption dates can be found in the 3 June 2021 announcement, the Company's 2022 Annual Report and the original acquisition circular, each of which are available on the Company's website.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

Following Admission and allotment of the shares, the Company's issued share capital will comprise 32,636,872 Ordinary Shares, which figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury.

 

For further information, contact:

Braemar Plc

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Nick Stone, Group Chief Financial Officer

 

Investec Bank Plc

Gary Clarence / Harry Hargreaves / Alice King

Tel +44 (0) 20 7597 5970

 

Cenkos Securities plc

Ben Jeynes / Max Gould (Corporate Finance)

Alex Pollen / Leif Powis (Sales)

 

Tel +44 (0) 20 7397 8900

 

Buchanan

Charles Ryland/ Stephanie Whitmore / Jack Devoy

Tel +44 (0) 20 7466 5000

 

Notes to Editors:

 

About Braemar

 

Braemar provides expert advice in shipping investment, chartering, and risk management to enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping.

Braemar's experienced brokers work in tandem with specialist professionals to form teams tailored to its customers' needs, and provides an integrated service supported by a collaborative culture.

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

For more information, including our investor presentation, please visit www.braemar.com and follow Braemar on LinkedIn.

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

 

Siepmann & Cie. Verwaltungs GmbH  

Reason for the notification

 

Position/status

 

Person closely associated with Axel Siepmann, Managing Director of Braemar Corporate Finance

Initial notification /Amendment

 

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

Name

 

Braemar Plc

LEI

 

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 10p each 

 

 

GB0000600931

Nature of the transaction 

 

Issue of ordinary shares of 10p each.

Price(s) and volume(s)

 

 

Price(s) 

Volume(s)

315.7

12,123

Aggregated information

- Aggregated volume

- Price

 

 

12,123 ordinary shares of 10p each 

£38,272.311

 

Date of the transaction

 

19 December 2022

Place of the transaction 

 

 

Outside of a trading venue

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

 

CFC Beteiligungsgesellschaft mbH  

Reason for the notification

 

Position/status

 

Person closely associated with Axel Siepmann, Managing Director of Braemar Corporate Finance

Initial notification /Amendment

 

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

Name

 

Braemar Plc

LEI

 

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 10p each 

 

 

GB0000600931

Nature of the transaction 

 

Issue of ordinary shares of 10p each.

Price(s) and volume(s)

 

 

Price(s) 

Volume(s)

315.7p

13,390

Aggregated information

- Aggregated volume

- Price

 

 

13,390 ordinary shares of 10p each 

£42,272.23

 

Date of the transaction

 

19 December 2022

Place of the transaction 

 

 

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGLBDDGBDDGDD
Date   Source Headline
1st Mar 20161:02 pmRNSTotal Voting Rights
25th Feb 20162:52 pmRNSDisclosure of Home Member State
27th Jan 20163:04 pmRNSBlocklisting Interim Review
27th Jan 20163:01 pmRNSBlocklisting Interim Review
14th Jan 20167:00 amRNSTrading Update
5th Jan 20164:40 pmRNSSecond Price Monitoring Extn
5th Jan 20164:35 pmRNSPrice Monitoring Extension
4th Jan 201610:14 amRNSTotal Voting Rights
26th Nov 20154:40 pmRNSSecond Price Monitoring Extn
26th Nov 20154:35 pmRNSPrice Monitoring Extension
2nd Nov 20151:47 pmRNSTotal Voting Rights
28th Oct 20157:00 amRNSInterim Results
7th Oct 20157:00 amRNSNotice of Results
23rd Sep 201510:27 amRNSHolding(s) in Company
28th Aug 20154:39 pmRNSTotal Voting Rights
27th Aug 20157:01 amRNSBlocklisting Interim Review
27th Aug 20157:01 amRNSBlocklisting Interim Review
27th Aug 20157:01 amRNSLaunch of SAYE Scheme
5th Aug 201511:03 amRNSTotal Voting Rights
8th Jul 201510:02 amRNSDirector/PDMR Shareholding
1st Jul 20157:53 amRNSTotal Voting Rights
24th Jun 20151:37 pmRNSResult of AGM and Appointment
24th Jun 201511:09 amRNSAGM Trading Update
5th Jun 20153:14 pmRNSDirector Notification
19th May 20157:00 amRNSPreliminary Results
9th Apr 20157:00 amRNSAnnouncement of Board changes
2nd Apr 20155:47 pmRNSTotal Voting Rights
31st Mar 20158:35 amRNSHolding(s) in Company
4th Mar 20155:25 pmRNSHolding(s) in Company
2nd Mar 20155:13 pmRNSHolding(s) in Company
2nd Mar 20152:02 pmRNSTotal Voting Rights
26th Feb 20157:00 amRNSInvestor site visit
2nd Feb 20154:30 pmRNSTotal Voting Rights
2nd Feb 20154:28 pmRNSBlocklisting Interim Review
2nd Feb 20154:27 pmRNSBlocklisting Interim Review
2nd Feb 20151:35 pmRNSDirector/PDMR Shareholding
29th Jan 201510:41 amRNSDirector/PDMR Shareholding
29th Jan 20158:21 amRNSAdditional Listing
28th Jan 20157:00 amRNSStrategic sale of Head Office
15th Jan 20157:00 amRNSInterim Management Statement
13th Jan 20151:03 pmRNSHolding(s) in Company
2nd Dec 201411:01 amRNSTotal Voting Rights
31st Oct 20144:25 pmRNSTotal Voting Rights
29th Oct 20147:00 amRNSHalf Yearly Report
4th Sep 20147:00 amRNSNotice of Results
1st Sep 20141:27 pmRNSBlocklisting Interim Review
1st Sep 20141:25 pmRNSBlocklisting Interim Review
1st Aug 20141:57 pmRNSTotal Voting Rights
1st Aug 201412:00 pmRNSHolding(s) in Company
31st Jul 20145:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.